Sitagliptin phosphate monohydrate is an active pharmaceutical ingredient used in the manufacturing of medications for type 2 diabetes. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, increasing insulin production and decreasing glucagon production by the pancreas.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 654671-78-0
Sitagliptin monohydrochloride monohydrate
active pharmaceutical ingredient
Sitagliptin tartrate hemihydrate
active pharmaceutical ingredient
Sitagliptin Hydrochloride
active pharmaceutical ingredient
시타글립틴
Dipeptidyl peptidase IV inhibitor
NAFTIFINE HYDROCHLORIDE
allylamine antifungal active pharmaceutical ingredient
Inositol hexanicotinate
Active pharmaceutical ingredient
Asenapine
active pharmaceutical ingredient
4'-Demethylepipodophyllotoxin
antineoplastic agent
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate
GQPYTJVDPQTBQC-KLQYNRQASA-N
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N.O.OP(=O)(O)O